Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biological Effects of LEO 43204 in Actinic Keratosis Assessed by Histopathology

NCT02600598 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT02600598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02600598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biological Effects of LEO 43204 in Actinic Keratosis Assessed by Histopathology
Lead sponsor
LEO Pharma
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2016
Completion date
January 16, 2017
Enrollment
24 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis